WINTERTHUR, Switzerland--(BUSINESS WIRE)--Cardiola AG announced today that a study (“Therapeutic Value of Muscular Counterpulsation After Coronary Bypass Grafting Operation”) published in the Journal of Cardiac Surgery (2009;24:134-140) demonstrates that “MCP (muscular counterpulsation) represents a new, noninvasive, ECG-triggered circulation support system, which is effective for achieving hemodynamic improvement via afterload reduction. The use of MCP decreases postoperative complications and significantly shortens the hospital stay.” The study’s principal investigator was Larry V. Lapanashvili, MD, a cardiac surgeon at Marji Medical Center, Tbilisi, Georgia.
